Treatment of clozapine associated obesity and diabetes with exenatide in people with schizophrenia
收藏DataCite Commons2024-04-12 更新2025-04-09 收录
下载链接：
https://mentalhealthnode.com.au/news/clinical-trial/treatment-of-clozapine-associated-obesity-and-diabetes-with-exenatide-in-people-with-schizophrenia/
下载链接
链接失效反馈官方服务：
资源简介：
Twenty-eight outpatients with schizophrenia (aged 18-64 years) were randomized to once-weekly extended-release subcutaneous exenatide or usual care for 24 weeks. The primary outcome was proportion of participants with >5% weight loss. All 28 participants completed the study; 3/14 in the exenatide group and 2/14 in the usual care group had type 2 diabetes.
提供机构：
University of Queensland
创建时间：
2023-06-14
